A Randomized, Double-blind, Phase 3 Study to Investigate the Efficacy and Safety of Teplizumab Compared with Placebo in Participants 1 to 25 Years of Age with Recently Diagnosed Stage 3 Type 1 Diabetes

Project: Research

Status	Active
Effective start/end date	10/9/25 → 12/29/28

Project Details